Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

RPR seeks approval for enoxaparin for unstable angina in Europe

June 18, 1997

3-Dimensional Pharmaceuticals licenses thrombin inhibitors to Wyeth-Ayerst

June 17, 1997

Chimeric molecule shows promise as thrombolytic therapy

June 11, 1997

Thomae prepares fibrinogen receptor antagonists

June 11, 1997

Novel fibrinogen antagonist from Merck & Co.

June 11, 1997

Thrombin inhibitors revealed by Merck & Co.

June 10, 1997

Merck & Co. fibrinogen antagonist characterized in animals

June 9, 1997

Fibrinogen antagonists from Merck & Co.

June 6, 1997

First launch for lepirudin

June 5, 1997

Orally active antiplatelet agents described by Taisho

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...